Type 2 Diabetes News and Research RSS Feed - Type 2 Diabetes News and Research

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Only few older adults use apps to help manage Type 2 diabetes, says new study

Only few older adults use apps to help manage Type 2 diabetes, says new study

Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians are living with Type 2 diabetes, 2 million of whom are age 50 or older. [More]
Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Eli Lilly and Company and Adocia today announced a worldwide licensing collaboration focused on developing an ultra-rapid insulin, known as BioChaperone Lispro, for treatment in people with type 1 and type 2 diabetes. [More]
Researchers examine why Mexican-Americans at increased risk for Type 2 diabetes

Researchers examine why Mexican-Americans at increased risk for Type 2 diabetes

While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin. [More]
Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors

Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors

Nutrition experts are continually debating the nutritional value of carbohydrate-containing foods and whether some are healthier than others. High carbohydrate foods are classified by how much they increase blood sugar; known as glycemic index. In new findings led by researchers at Brigham and Women's Hospital in Boston and Johns Hopkins University in Baltimore, researchers looked at glycemic index' effect on cardiovascular disease (CVD) and diabetes and found that low glycemic diets did not improve insulin sensitivity or cardiovascular risk factors. [More]
Joslin study could lead to improved anti-aging drugs

Joslin study could lead to improved anti-aging drugs

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it--and might even lead to better cosmetics. [More]
ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290. [More]
ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
New study finds that immune cells in the brain may contribute to obesity

New study finds that immune cells in the brain may contribute to obesity

Immune cells perform a previously unsuspected role in the brain that may contribute to obesity, according to a new study by UC San Francisco researchers. [More]
UR researchers on track to solve mystery of weight gain

UR researchers on track to solve mystery of weight gain

University of Rochester researchers believe they're on track to solve the mystery of weight gain - and it has nothing to do with indulging in holiday eggnog. [More]
Study finds link between hypoglycaemia and increased risk of cardiovascular events

Study finds link between hypoglycaemia and increased risk of cardiovascular events

A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes. [More]
Study examines why young people with Type-2 diabetes develop heart problems

Study examines why young people with Type-2 diabetes develop heart problems

A new study led by a research team at Leicester's Hospitals hope to reveal, using magnetic resonance imaging (MRI), why young people with Type-2 diabetes develop heart damage. [More]
Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects. [More]
McGill University scientists show how simple potato extract can fight obesity

McGill University scientists show how simple potato extract can fight obesity

Take a look in your pantry: the miracle ingredient for fighting obesity may already be there. A simple potato extract may limit weight gain from a diet that is high in fat and refined carbohydrates, according to scientists at McGill University. The results of their recent study were so surprising that the investigators repeated the experiment just to be sure. [More]
Weight loss surgery and exercise lower risks of serious health problems

Weight loss surgery and exercise lower risks of serious health problems

Throughout the past year, studies on the positive effects of weight loss surgery have been published in a variety of medical journals in the US and abroad. We learned that weight loss surgery is relatively safe, and that it is effective in improving serious health conditions. More recently, we also learned that it is a factor in preventing Type 2 diabetes from developing in people considered to be pre-diabetic. [More]
Triple hormone reduces body weight, improves insulin sensitivity

Triple hormone reduces body weight, improves insulin sensitivity

Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials. [More]
Experts launch new interdisciplinary scientific collaboration to improve health in urban areas

Experts launch new interdisciplinary scientific collaboration to improve health in urban areas

Aiming to empower planners and policy-makers to achieve better health for billions of people living in fast-growing urban areas, world health, environmental, behavioural and social science experts today launched a major new interdisciplinary scientific collaboration. [More]
Weight-loss surgery may reduce lower urinary tract symptoms

Weight-loss surgery may reduce lower urinary tract symptoms

Metabolic syndrome is linked with an increased frequency and severity of lower urinary tract symptoms, but weight loss surgery may lessen these symptoms. The findings, which come from two studies published in BJU International, indicate that urinary problems may be added to the list of issues that can improve with efforts that address altered metabolism. [More]
Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Type 1 diabetes is a complex condition to manage. It requires continuous, around the clock monitoring of blood glucose levels, which change repeatedly throughout the day and night. [More]
Janssen, American Diabetes Association team up to launch national educational campaign on diabetes

Janssen, American Diabetes Association team up to launch national educational campaign on diabetes

Janssen Pharmaceuticals, Inc. today announced a collaboration with the American Diabetes Association to launch Teaming Up to Take On Diabetes, a national educational campaign intended to help the nearly 30 million Americans living with diabetes better understand and manage the disease. [More]
Risk of developing obesity, type 2 diabetes and cardiovascular disease starts in pregnancy

Risk of developing obesity, type 2 diabetes and cardiovascular disease starts in pregnancy

The risk of developing type 2 diabetes, obesity, and cardiovascular disease is affected by exposures in the uterus. Researchers at Lund University in Sweden are now calling for updated guidelines in light of research evidence from the past decades. [More]